PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 271717

Hyperbaric oxygenation: prosthodontic responsibilities.

J M Young·R L Bump
View original source ↗Export metadata ↓

Abstract

This article discussed the use of hyperbaric oxygen in the treatment of chronic osteomyelitis, osteoradionecrosis, and nonhealing wounds. The fabrication of custom-fitted oxygen applicators is presented, and specific recommendations are made for their use. The prosthodontist serves as a valuable member of the hyperbaric treatment team. His professional knowledge and technical expertise allow him to construct treatment applicators which are professionally sound and provide comfort for the patient.

Explore related subjects

Administration, TopicalChronic DiseaseFacial BonesHumansHyperbaric OxygenationJaw DiseasesMandibular DiseasesOsteomyelitisOsteoradionecrosisOxygenProsthodonticsRadiation InjuriesWound HealingJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J M Young, R L Bump. 1978. Hyperbaric oxygenation: prosthodontic responsibilities.. https://doi.org/10.1016/s0022-3913(78)80055-9

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed1992

Synthesis and physicochemical properties of sulfamate derivatives as topical antiglaucoma agents.

Several imidazolylphenyl sulfamate and (imidazolylphenoxy)alkyl sulfamate derivatives were synthesized and evaluated as topically active carbonic anhydrase inhibitors. Water solubility, pKa, carbonic anhydrase inhibition, and partition coefficient for the compounds were measured. Sulfamic acid 2-[4-(1H-imidazol-1-yl)phenoxy]ethyl ester monohydrochloride (16) has the best combination of properties and showed excellent topical activity in lowering the intraocular pressure in New Zealand white rabbits.

Administration, Topical↗
PubMed1992

Results of intraoperative 5-fluorouracil supplementation on trabeculectomy for open-angle glaucoma.

The success rate of filtration surgery has been increased by the postoperative subconjunctival injection of 5-fluorouracil, a potent antimetabolite. However, the optimal route of administration has not been determined. Trabeculectomy was performed on one eye each of 14 patients. Topical 5-fluorouracil was applied intraoperatively (50 mg/ml for five minutes) and subconjunctival 5-fluorouracil was injected postoperatively (an average of 5.8 injections) (mean total dose, 29 mg). Seven of the 14 eyes had primary open-angle glaucoma, and seven eyes had open-angle glaucoma with either uveitis, aphakia, or previous failed trabeculectomy. Mean preoperative intraocular pressure was 24.7 mm Hg during treatment with an average of three antiglaucoma medications, and mean final intraocular pressure was 11.9 mm Hg during treatment with an average of 0.2 medication. Thirteen of 14 eyes (93%) had final intraocular pressure of 18 mm Hg or less. Mean follow-up was 6.4 months (range, four to nine months). No remarkable complications occurred. Visual acuity remained stable in 13 of 14 eyes (93%). Intraoperative 5-fluorouracil may be a helpful adjunct in achieving low final intraocular pressure after trabeculectomy.

Administration, Topical↗
PubMed1992

[Pannus].

Explore the source record for details and available documents.

Administration, Topical↗